Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mCPP Effects on Appetite and Cognition in Lean and Obese Women
NCT03962829Terminated
- Sponsor
- University of Birmingham
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of meta-chlorophenylpiperazine in obesity, sponsored by University of Birmingham. Primary endpoint: fMRI brain response during food reward processes. Started Feb 2019; status: terminated.
02
Drugs
meta-chlorophenylpiperazine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03962829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962829.